Key result
The use of low-cost smartwatches for out-of-clinic blood pressure monitoring among expectant mothers faced significant challenges, with only 3 of 34 mothers taking consistent readings.
Why the study?
Smartwatch-based ABPM and HBPM could detect pre-eclampsia early, but these devices and monitoring practices have not been widely adopted in developing countries due to high costs and lack of healthcare system institutionalization.
Cohort (n=34)
Yes
The use of low-cost smartwatches for home blood pressure monitoring in pregnant women in a developing country setting demonstrated poor feasibility due to significant technical and adherence issues.
No takes yet. Share an insight, caveat, or question.
Significant adherence barriers indicate low-cost smartwatches are unsuitable for home BP monitoring in pregnancy; leaves open feasibility of improved wearables.
Thiga et al. (2023) conducted a cohort in Pregnancy (monitoring for pre-eclampsia) (n=34). Smartwatch and mobile application for blood pressure monitoring was evaluated on Feasibility and adherence to out-of-clinic blood pressure monitoring. The use of low-cost smartwatches for out-of-clinic blood pressure monitoring among expectant mothers faced significant challenges, with only 3 of 34 mothers taking consistent readings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: